(Q28248065)
Statements
Randomized phase III trial results of panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer (English)
0 references
May 2006
0 references
6
0 references
1
0 references
29-31
0 references